Skip to content

MRI protocol development for all field strengths

MRI protocol development for all field strengths - MRI protocol development

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50552
Enrollment
75
Registered
2015-12-04
Start date
2016-01-02
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

geen specifieke aandoening te benoemen. de ontwikkelde protocollen en beeldverwerkingstechnieken kunnen voor verschillende aandoeningen worden gebruikt. Protocol development

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - >= 18 years - Capable and prepared to sign an informed consent

Exclusion criteria

Exclusion criteria: - Contraindication for MRI scanning as listed in the MRI screening form, according to the current MR safety guidelines - Neurological or psychiatric diagnosis - (possible) pregnancy -Refusal of subjects to be informed of chance findings possibly relevant to their health In the event that the RespirAct system is used for a sub-study: - Unwilling or unable to cooperate with breathing protocol or keeping still; - Medical contraindications to limited hypercapnia (known metabolic acidosis or alkalosis); - Standard contraindications for using the RespirAct RA-MRTM MRI UNIT (see D2 IMDD 2.5 contraindications); - Known cerebrovascular, cardiovascular or pulmonary (or other) disease - concurrent severe or uncontrolled medical disease (e.g., active systemic infection);

Design outcomes

Primary

MeasureTime frame
The development and optimization of new and existing MRI protocols and processing techniques required for anatomical and functional imaging in the research and clinical setting. In addition new methods will be developed for image processing.

Secondary

MeasureTime frame
Not applicable.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)